The global bioabsorbable vascular scaffolds market size is expected to reach USD 300.24 million by 2028, at a CAGR of 13.9%  during the forecast period 2022-28. Coronary heart disease, cerebrovascular illness, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism are the most common cardiovascular disorders, which impact millions of individuals around the world. The prevalence of cardiovascular diseases has risen dramatically, particularly in Asia and the Pacific. The prevalence of cardiovascular diseases is higher in Western countries such as the United States, the United Kingdom, Germany, France, and Russia. Patients with various types of cardiovascular disorders benefit from bioresorbable vascular scaffolds such as poly-L-lactide (PLLA) bioresorbable scaffolds, metallic bioresorbable scaffolds, and hybrid bioresorbable scaffolds. The number of people with cardiovascular disorders admitted to hospitals, both inpatient and outpatient, has risen dramatically. For the treatment of CVDs, a shift from traditional metallic stents to bioresorbable vascular scaffolds has been noted.

View detailed report description here https://precisionbusinessinsights.com/market-reports/global-bioabsorbable-vascular-scaffolds-market/                   

One of the primary factors driving the growth of the bioresorbable scaffolds market is the rise in the prevalence of cardiovascular diseases (CVD) among the global population. The bioresorbable scaffolds market is expected to develop due to an increase in adoption for cardiovascular procedures due to several benefits such as full absorption by the body and an increase in the incidence of lifestyle-related disorders such as diabetes and obesity, among others. The bioresorbable scaffolds market is also influenced by the rise in adoption of bad lifestyle behaviours such as alcohol use, poor diet, and lack of exercise, as well as advancements developed by key companies to naturally restore arterial movement. Furthermore, changing lifestyles, population expansion, an increase in the number of cardiovascular procedures, and an increase in healthcare spending all benefit the bioresorbable scaffolds market. Furthermore, in the forecast period of 2021 to 2028, research and development initiatives to prevent vessel recoil that allows secretion of anti-proliferative drugs expand profitable potential for bioresorbable scaffolds market players. The high cost of bioresorbable scaffolds, on the other hand, is projected to stifle the bioresorbable scaffolds market's growth. In the forecast period of 2021-2028, the rising demand for vascular graft devices for angioplasty and coronary artery disorders is expected to pose a threat to the bioresorbable scaffolds market.

The global bioabsorbable vascular scaffolds market segmentation:
1) By Type: Metal based BVS, Polymer based BVS.
2) By Application: Coronary Artery Stents, Peripheral Artery Stents
 3) By End-User: Hospitals, Cardiac Centres, Ambulatory Surgical Centres.

Due to the large number of people suffering from cardiovascular diseases, the rise in obese and diabetic populations, the rise in stress and desk-bound lifestyles, the large geriatric population, and the presence of a number of leading companies, North America dominates the bioresorbable scaffolds market. Because of significant technological advancements and a large number of patients suffering from various vascular illnesses, Asia-Pacific is predicted to increase at the quickest rate from 2021 to 2028.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=15795                          

Some of the major key players in the bioabsorbable vascular scaffolds market are Medtronic (U.S.) Abbott Laboratories (U.S) Boston Scientific Corporation (U.S.) Biosensors International Group, Ltd. (Singapore) Biotronik SE & Co. KG (Germany) C.R. Bard Inc. (U.S.) Stentys SA (France) Svelte Medical Systems, Inc. (U.S.) REVA Medical, Inc. (U.S.)

About Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174